Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
QKI - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
POLR3GL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NEDD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IAH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC283484 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors
ZBTB41 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
UBLCP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTMR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IDH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSPAN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CFP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LAPTM4A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PKIB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEFF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MKLN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on